4.4 Review

Pharmaceutical nanotechnology: which products are been designed against COVID-19?

期刊

JOURNAL OF NANOPARTICLE RESEARCH
卷 22, 期 9, 页码 -

出版社

SPRINGER
DOI: 10.1007/s11051-020-05010-6

关键词

Nanomedicine; Nanotechnology products; COVID-19; SARS-CoV-2

资金

  1. Council for Scientific and Technological Development (CNPq)
  2. CNPq [427243/2016-5, 141307/2020-0]

向作者/读者索取更多资源

The current pandemic COVID-19, caused by the SARS-CoV-2 virus, has been affecting thousands of people worldwide, promoting high numbers of deaths. With this, the world population is going through a process of changing habits, with social distance, improvement of hygiene techniques, to reduce the spread of the SARS-CoV-2 virus and, consequently, reduce the number of hospitalized people in serious condition, as well as the mortality rate. This scenario has been promoting a continuous search for researchers, in the most varied areas, for possible methods of prevention or cure. Specifically, in the field of pharmaceutical nanotechnology, a variety of products are being developed against SARS-CoV-2. Under these circumstances, we propose here an exposition of some of the nanotechnological products (nanoscale between 1 to 1000 nm) currently designed for the detection of the virus, for the prevention and treatment of COVID-19, in addition to equipment for personal protection. We believe that pharmaceutical nanotechnology will be a valuable tool in the disease from the development of products that guarantee our protection against the SARS-CoV-2 virus.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据